“Rosary Sign” at Somatostatin Receptor PET in a Case of Recurrent Meningioma
We present the case of a 60-year-old male with recurrent atypical meningioma in the right parietal lobe, previously treated with surgery and radiation therapy. Magnetic resonance imaging (MRI) performed 5 years after radiation therapy suggested a possible recurrence. A somatostatin receptor positron emission tomography/computed tomography (SR-PET/CT) scan with Gallium-68 DOTATATE was performed to confirm this suspicion. SR-PET/CT confirmed the presence of recurrent meningioma, showing a novel "rosary sign" with multiple adjacent areas of focal tracer uptake along the resection margins of the previous surgical site in the right parietal region. This novel imaging pattern improved diagnostic accuracy by detailing disease extent and identifying additional lesions not visible via MRI. Given the failure of prior treatments and high SR expression, peptide receptor radionuclide therapy (PRRT) was proposed as a therapeutic option for the patient.
Authors
- Giorgio Treglia (ORCID: https://orcid.org/0000-0001-9808-780X)
- Gaetano Paone (ORCID: https://orcid.org/0000-0003-2864-5364)
- Davide Giovanni Bosetti (ORCID: https://orcid.org/0000-0002-2654-1281)
- Marco Cuzzocrea (ORCID: https://orcid.org/0000-0002-8214-562X)
- Barbara Muoio (ORCID: https://orcid.org/0000-0003-1547-8536)
- Cesare Michele Iacovitti (ORCID: https://orcid.org/0009-0000-8951-382X)
Institutions
- Ente Ospedaliero Cantonale (CH)
- Istituto Imaging della Svizzera Italiana
- Università della Svizzera italiana (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- Diagnostics
- Published
- 2024-11-20
- DOI
- https://doi.org/10.3390/diagnostics14222608
- Citations
- 1
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.39